The driver event in the pathogenesis of chronic myeloid leukemia (CML) is the t(9;22) chromosomal translocation, resulting in a BCR::ABL1 fusion gene that encodes a protein with constitutively active tyrosine kinase activity.1 The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.